UPDATE : Wednesday, August 5, 2020
HOME Policy
Korea’s overseas medical projects help foreigners deal with COVID-19
  • By Shim Hyun-tai
  • Published 2020.04.06 18:07
  • Updated 2020.04.06 18:07
  • comments 0

As the demand rises for the Korean healthcare sector’s overseas advance amid the COVID-19 pandemic, the Korea Health Industry Development Institute (KHIDI)’s customized support system is also bearing results, the state-invested organization said.

A case in point is the project called the Seegene Medical Foundation – Korean Clinical Laboratories (SKL), jointly run by Seegene and Medical Partners Korea (MPK), it said.

SKL will conduct diagnostic tests on symptomatic people in Kazakhstan along with the local health authorities like the state examination agency designated by the Central Asian country, beginning from March 26. Earlier, KHIDI selected SKL for undertaking overseas medical advancement project and has been providing support for the project operators.

MPK opened a general hospital in the country’s capital, Almaty, in October 2018, and has been treating about 20,000 patients.

To upgrade its diagnosing capacity to the Korean level, MPK opened SKL within the hospital in partnership with Seegene, which specializing in diagnosis on contract. The team has been providing high-quality diagnostic tests for more than 30 local hospitals, clinics, and insurance companies.

Seegene Medical Foundation and MPK were selected for Korea’s medical overseas advancement project to lead the expansion of the Korean medical package, which includes medical service, pharmaceuticals, and medical information technology.

The agreement was signed after consulting the details and with the Kazakhstan government and licensing authorities with the active support of the KHIDI branch in Kazakhstan.

Kazakhstan’s health authorities instructed to commission SKL for testing COVID-19 in Almaty in February to protect their people from the COVID-19 infections, acknowledging its problems, such as lack of special facilities and specialized personnel, reagents, and equipment for inspection and made the decision.

Kazakhstan lacked specialized molecular diagnostics test centers with biosafety level 2 as graded by the U.S. Clinical Laboratory Improvement Amendments (CLIA).

Starting with the contract, MPK and Seegene Medical Foundation will not only expand the export of diagnostic kits but also contribute to creating social value through national health and medical cooperation and the supply of advanced technology from Korea.

The companies are planning to expand their business in Russia and major cities as the Moon Jae-in government categorized as the “new northern region.”

“The agreement is significant as Korea successfully exported healthcare equipment and technology, and diagnostic reagents, to a nation that lacks early diagnosis capabilities and infrastructure amid the pandemic,” KHIDI Manager Chung Hye-won said.


<© Korea Biomedical Review, All rights reserved.>

Other articles by Shim Hyun-tai
iconMost viewed
Comments 0
Please leave the first comment.
Back to Top